69 related articles for article (PubMed ID: 9324301)
1. Expression of interleukin-6 receptors by pediatric acute lymphoblastic leukemia cells with the t(4;11) translocation: a possible target for therapy with recombinant IL6-Pseudomonas exotoxin.
Gu L; Zhou M; Jurickova I; Yeager AM; Kreitman RJ; Phillips CN; Findley HW
Leukemia; 1997 Oct; 11(10):1779-86. PubMed ID: 9324301
[TBL] [Abstract][Full Text] [Related]
2. Pediatric acute myelogenous leukemia cells express IL-6 receptors and are sensitive to a recombinant IL6-Pseudomonas exotoxin.
Boayue KB; Gu L; Yeager AM; Kreitman RJ; Findley HW
Leukemia; 1998 Feb; 12(2):182-91. PubMed ID: 9519780
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 fused to a mutant form of Pseudomonas exotoxin kills malignant cells from patients with multiple myeloma.
Kreitman RJ; Siegall CB; FitzGerald DJ; Epstein J; Barlogie B; Pastan I
Blood; 1992 Apr; 79(7):1775-80. PubMed ID: 1558971
[TBL] [Abstract][Full Text] [Related]
4. Human renal cell carcinoma cells are sensitive to the cytotoxic effect of a chimeric protein composed of human interleukin-4 and Pseudomonas exotoxin.
Puri RK; Debinski W; Obiri N; Kreitman R; Pastan I
Cell Immunol; 1994 Apr; 154(1):369-79. PubMed ID: 8131209
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acute myelocytic leukemia with interleukin-6 Pseudomonas exotoxin fusion protein in a rat leukemia model.
Rozemuller H; Rombouts WJ; Touw IP; FitzGerald DJ; Kreitman RJ; Pastan I; Hagenbeek A; Martens AC
Leukemia; 1996 Nov; 10(11):1796-803. PubMed ID: 8892684
[TBL] [Abstract][Full Text] [Related]
6. [Specific cytotoxicity of recombinant interleukin 6-pseudomonas exotoxin fusion protein (IL6-PE40) on LT12 leukemic cells expressing high levels of interleukin 6 receptor (IL6R)].
Xi YZ
Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):419-22. PubMed ID: 8200278
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of IL6-PE4E, a recombinant fusion of interleukin 6 with Pseudomonas exotoxin.
Kreitman RJ; Pastan I
Bioconjug Chem; 1993; 4(6):581-5. PubMed ID: 8305530
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of IL6-PE40 and derivatives on tumor cells expressing a range of interleukin 6 receptor levels.
Siegall CB; FitzGerald DJ; Pastan I
J Biol Chem; 1990 Sep; 265(27):16318-23. PubMed ID: 2118904
[TBL] [Abstract][Full Text] [Related]
9. Cell-specific toxicity of a chimeric protein composed of interleukin-6 and Pseudomonas exotoxin (IL6-PE40) on tumor cells.
Siegall CB; Nordan RP; FitzGerald DJ; Pastan I
Mol Cell Biol; 1990 Jun; 10(6):2443-7. PubMed ID: 2160579
[TBL] [Abstract][Full Text] [Related]
10. A wide range of human cancers express interleukin 4 (IL4) receptors that can be targeted with chimeric toxin composed of IL4 and Pseudomonas exotoxin.
Debinski W; Puri RK; Kreitman RJ; Pastan I
J Biol Chem; 1993 Jul; 268(19):14065-70. PubMed ID: 8314773
[TBL] [Abstract][Full Text] [Related]
11. A chimeric protein comprised of IL-4 and Pseudomonas exotoxin is cytotoxic for activated human lymphocytes.
Puri RK; Mehrotra PT; Leland P; Kreitman RJ; Siegel JP; Pastan I
J Immunol; 1994 Apr; 152(7):3693-700. PubMed ID: 8144944
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of interleukin 6-Pseudomonas exotoxin chimeric molecules against the human hepatocellular carcinoma, PLC/PRF/5 in mice.
Siegall CB; Kreitman RJ; FitzGerald DJ; Pastan I
Cancer Res; 1991 Jun; 51(11):2831-6. PubMed ID: 1851660
[TBL] [Abstract][Full Text] [Related]
13. Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL4-Pseudomonas exotoxin chimeric protein.
Puri RK; Leland P; Kreitman RJ; Pastan I
Int J Cancer; 1994 Aug; 58(4):574-81. PubMed ID: 8056454
[TBL] [Abstract][Full Text] [Related]
14. Selective killing of IL6 receptor bearing myeloma cells using recombinant IL6-Pseudomonas toxin.
Siegall CB; FitzGerald DJ; Pastan I
Curr Top Microbiol Immunol; 1990; 166():63-9. PubMed ID: 2127396
[No Abstract] [Full Text] [Related]
15. [Molecular design and construction of IL6D24-PE40KDEL, a novel recombinant interleukin6-pseudomonas exotoxin fusion protein, having targeted cytotoxicity for leukemias expressing interleukin6 receptors].
Zheng LY; Xi YZ; Kong FH; Cui JW; Liang F; Liu N; Sun YY; Guo SQ
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(14):1246-50. PubMed ID: 12930640
[TBL] [Abstract][Full Text] [Related]
16. A human acute lymphoblastic leukemia line with the T(4;11) translocation as a model of minimal residual disease in SCID mice.
Gobbi A; Di Berardino C; Scanziani E; Garofalo A; Rivolta A; Fontana G; Rambaldi A; Giavazzi R; Biondi A
Leuk Res; 1997; 21(11-12):1107-14. PubMed ID: 9444945
[TBL] [Abstract][Full Text] [Related]
17. Soluble interleukin-6 receptors in hematology patients undergoing bone marrow transplantation.
Toren A; Novick D; Or R; Ackerstein A; Slavin S; Nagler A
Transplantation; 1996 Jul; 62(1):138-42. PubMed ID: 8693533
[TBL] [Abstract][Full Text] [Related]
18. Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells.
Siegall CB; Schwab G; Nordan RP; FitzGerald DJ; Pastan I
Cancer Res; 1990 Dec; 50(24):7786-8. PubMed ID: 2253221
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer cells express interleukin-13 and -4 receptors, and their growth is inhibited by Pseudomonas exotoxin coupled to interleukin-13 and -4.
Kornmann M; Kleeff J; Debinski W; Korc M
Anticancer Res; 1999; 19(1A):125-31. PubMed ID: 10226533
[TBL] [Abstract][Full Text] [Related]
20. Analysis of antitumor activity of an interleukin-13 (IL-13) receptor-targeted cytotoxin composed of IL-13 antagonist and Pseudomonas exotoxin.
Kioi M; Kawakami K; Puri RK
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6231-8. PubMed ID: 15448012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
